A comprehensive spectroscopic study of the polymorphs of diflunisal and their phase transformations

Anuradha R. Pallipurath, Francesco Civati, Juraj Sibik, Clare Crowley, J. Axel Zeitler, Patrick McArdle, Andrea Erxleben

Research output: Contribution to journalArticle

7 Citations (Scopus)
161 Downloads (Pure)

Abstract

Understanding phase transitions in pharmaceutical materials is of vital importance for drug manufacturing, processing and storage. In this paper we have carried out comprehensive high-resolution spectroscopic studies on the polymorphs of the non-steroidal anti-inflammatory drug diflunisal that has four known polymorphs, forms I–IV (FI–FIV), three of which have known crystal structures. Phase transformations during milling, heating, melt-quenching and exposure to high relative humidity were investigated using Raman and terahertz spectroscopy in combination with differential scanning calorimetry and X-ray powder diffraction. The observed phase transformations indicate the stability order FIII > FI > FII, FIV. Furthermore, crystallization experiments from the gas phase and from solution by fast evaporation of different solvents were carried out. Fast evaporation of an ethanolic solution below 70 °C was identified as a reliable and convenient method to obtain the somewhat elusive FII in bulk quantities.

Original languageEnglish
Pages (from-to)312-321
Number of pages10
JournalInternational Journal of Pharmaceutics
Volume528
Issue number1-2
Early online date8 Jun 2017
DOIs
Publication statusPublished - Aug 2017

Keywords

  • Diflunisal
  • Phase transformation
  • Polymorphs
  • Terahertz spectroscopy

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'A comprehensive spectroscopic study of the polymorphs of diflunisal and their phase transformations'. Together they form a unique fingerprint.

Cite this